Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma Stage Iii”

721 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 721 results

Testing effectiveness (Phase 2)Ended earlyNCT01533948
What this trial is testing

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Extraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more
Roswell Park Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT01961115
What this trial is testing

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Mucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more
Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)WithdrawnNCT01851408
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)UnknownNCT00006249
What this trial is testing

Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 1,258
Large-scale testing (Phase 3)Study completedNCT00769704
What this trial is testing

Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

Who this might be right for
Melanoma
BioVex Limited 437
Testing effectiveness (Phase 2)Active Not RecruitingNCT03999749
What this trial is testing

A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
NYU Langone Health 71
Testing effectiveness (Phase 2)Study completedNCT00135408
What this trial is testing

MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide

Who this might be right for
Malignant Melanoma
Bristol-Myers Squibb 115
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT02073123
What this trial is testing

Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage III MelanomaStage IV Melanoma
NewLink Genetics Corporation 132
Large-scale testing (Phase 3)Ended earlyNCT00036816
What this trial is testing

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Who this might be right for
Intraocular Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 13
Early research (Phase 1)Active Not RecruitingNCT03161431
What this trial is testing

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Syntrix Biosystems, Inc. 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT01134614
What this trial is testing

Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Advanced MelanomaMetastatic MelanomaRecurrent Melanoma+6 more
National Cancer Institute (NCI) 245
Early research (Phase 1)Study completedNCT00349206
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI) 69
Large-scale testing (Phase 3)Looking for participantsNCT03755739
What this trial is testing

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Who this might be right for
HepatocarcinomaLung CancerMelanoma+7 more
Second Affiliated Hospital of Guangzhou Medical University 200
Large-scale testing (Phase 3)Study completedNCT01983748
What this trial is testing

Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

Who this might be right for
Uveal Melanoma
University Hospital Erlangen 200
Very early researchLooking for participantsNCT04741997
What this trial is testing

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVBRAF V600 Mutation
H. Lee Moffitt Cancer Center and Research Institute 50
Early research (Phase 1)UnknownNCT00006035
What this trial is testing

Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Active Not RecruitingNCT03769155
What this trial is testing

VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma

Who this might be right for
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8Pathologic Stage IIID Cutaneous Melanoma AJCC v8
Emory University 41
Not applicableStudy completedNCT02129049
What this trial is testing

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

Who this might be right for
Breast CancerCervical CancerColon Cancer+5 more
University of Washington 35
Large-scale testing (Phase 3)Ended earlyNCT01546571
What this trial is testing

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Who this might be right for
Melanoma
Polynoma LLC 504
Load More Results